Tonix Pharmaceuticals Holding (TNXP) EV to CFO (2014 - 2026)

Tonix Pharmaceuticals Holding has reported EV to CFO for 13 years, with the latest figure at 0.9 in Q2 2026.

• On a quarterly basis, EV to CFO rose 90.81% year-over-year to 0.9 in Q2 2026; TTM through Jun 2026 was 0.25, a 88.9% increase from a year earlier, with the FY2025 full-year figure at 0.75, down 39.54% from the prior year.
• EV to CFO was 0.9 for Q2 2026 at Tonix Pharmaceuticals Holding, down from 0.23 in the prior quarter.
• The five-year high for EV to CFO was 5.2 in Q2 2022, with the low at 9.79 in Q2 2025.
• Average EV to CFO over 5 years is 0.72, with a median of 0.46 recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: EV to CFO jumped 923.82% in 2024, then tumbled 7593.64% in 2025.
• Over 5 years, EV to CFO stood at 4.78 in 2022, then slumped by 82.17% to 0.85 in 2023, then jumped by 504.77% to 5.15 in 2024, then tumbled by 63.44% to 1.88 in 2025, then plunged by 147.8% to 0.9 in 2026.
• The last three EV to CFO figures came in at 0.9 (Q2 2026), 0.23 (Q1 2026), and 1.88 (Q4 2025), per Business Quant data.